Deva Holding AS
Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and … Read more
Deva Holding AS (DEVA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.058x
Based on the latest financial reports, Deva Holding AS (DEVA) has a cash flow conversion efficiency ratio of 0.058x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL1.53 Billion) by net assets (TL26.48 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Deva Holding AS - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Deva Holding AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Deva Holding AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Deva Holding AS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yatra Online Limited
NSE:YATRA
|
-0.026x |
|
Advanced Optoelectronic Technology Inc
TW:3437
|
-0.006x |
|
Pyrophyte Acquisition Corp
NYSE:PHYT
|
-0.012x |
|
Groupe Pizzorno Environnement SA
PA:GPE
|
0.332x |
|
Upexi Inc.
NASDAQ:UPXI
|
0.102x |
|
Berjaya Land Bhd
KLSE:4219
|
-0.032x |
|
Equillium Inc
NASDAQ:EQ
|
-0.273x |
|
Eolus Vind AB Series B
LSE:0R8F
|
-0.172x |
Annual Cash Flow Conversion Efficiency for Deva Holding AS (2005–2024)
The table below shows the annual cash flow conversion efficiency of Deva Holding AS from 2005 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | TL20.81 Billion | TL5.07 Billion | 0.243x | -27.39% |
| 2023-12-31 | TL21.34 Billion | TL7.16 Billion | 0.335x | +61.80% |
| 2022-12-31 | TL3.94 Billion | TL815.91 Million | 0.207x | -54.69% |
| 2021-12-31 | TL2.73 Billion | TL1.25 Billion | 0.457x | +15.74% |
| 2020-12-31 | TL1.63 Billion | TL645.98 Million | 0.395x | -7.66% |
| 2019-12-31 | TL1.03 Billion | TL441.24 Million | 0.428x | +143.91% |
| 2018-12-31 | TL746.41 Million | TL130.98 Million | 0.175x | -4.20% |
| 2017-12-31 | TL605.09 Million | TL110.84 Million | 0.183x | -49.88% |
| 2016-12-31 | TL512.85 Million | TL187.44 Million | 0.365x | +86.96% |
| 2015-12-31 | TL453.11 Million | TL88.58 Million | 0.195x | +56.38% |
| 2014-12-31 | TL411.91 Million | TL51.49 Million | 0.125x | +0.69% |
| 2013-12-31 | TL403.05 Million | TL50.04 Million | 0.124x | +618.95% |
| 2012-12-31 | TL378.63 Million | TL6.54 Million | 0.017x | -67.04% |
| 2005-12-31 | TL114.50 Million | TL6.00 Million | 0.052x | -- |